Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Controlled-release CNP agonists with reduced side-effects

Controlled-release CNP agonists with reduced side-effects

US Patent 11389511 · Granted Jul 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Incremental dose finding in controlled-release PTH compounds2025
Incremental dose finding in controlled-release PTH compounds2025
Liquid pharmaceutical formulations of PTH conjugates2025
Liquid pharmaceutical formulations of PTH conjugates2025
Dry pharmaceutical formulations of CNP conjugates2025
Long-acting growth hormone dosage forms with superior efficacy to daily somatrop2025
Controlled-release PTH compound2025
PEGylated recombinant human growth hormone compounds2025
PEGylated recombinant human growth hormone compounds2025
PEGylated recombinant human growth hormone compounds2025
Hydrogel cross-linked hyaluronic acid prodrug compositions and methods2025
Controlled-release CNP agonists with low initial NPR-B activity2025